Okyo Pharma (OKYO) chairman Gabriele Cerrone has increased his stake in the clinical-stage company to 10.9 million shares, or 20.5% of the company's issued shares, with the purchase of 25,000 ordinary shares at $1.40 per share, the company said Tuesday.
The purchase was made through Panetta Partners, an entity in which Cerrone has a beneficial interest, the company said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments